How Big Will the SpaceX IPO Be?
Operated up to now as a private business, SpaceX will…
Buy
60
AVNS Quote, Financials, Valuation and Earnings
Last price:
$13.34
Seasonality move
:
0.21%
Day range:
$12.85 - $13.45
52-week range:
$9.30 - $17.57
Dividend yield:
0%
P/E ratio:
45.94x
P/S ratio:
0.88x
P/B ratio:
0.79x
Volume:
587.1K
Avg. volume:
574K
1-year change:
-23.67%
Market cap:
$618.3M
Revenue:
$687.8M
EPS (TTM):
-$10.19
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
AVNS
Avanos Medical, Inc.
|
$175.9M | $0.24 | -2.73% | 30.01% | $14.00 |
|
IVF
INVO Fertility, Inc.
|
$1.8M | -- | -8.8% | -- | -- |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$2.7M | -- | -57.64% | -57.14% | $2.30 |
|
NTRB
Nutriband, Inc.
|
$765K | -$0.17 | 4.52% | -54.85% | $15.00 |
|
NVNO
enVVeno Medical Corp.
|
-- | -$0.28 | -- | -9.68% | $12.50 |
|
SINT
SINTX Technologies, Inc.
|
$400K | -$0.55 | -44.65% | -56.43% | $12.25 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
AVNS
Avanos Medical, Inc.
|
$13.32 | $14.00 | $618.3M | 45.94x | $0.00 | 0% | 0.88x |
|
IVF
INVO Fertility, Inc.
|
$1.37 | -- | $20.7M | -- | $0.00 | 0% | 0.03x |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$0.89 | $2.30 | $44.6M | -- | $0.00 | 0% | 2.94x |
|
NTRB
Nutriband, Inc.
|
$4.79 | $15.00 | $58.2M | -- | $0.00 | 0% | 23.90x |
|
NVNO
enVVeno Medical Corp.
|
$11.93 | $12.50 | $7.8M | -- | $0.00 | 0% | 473.07x |
|
SINT
SINTX Technologies, Inc.
|
$3.21 | $12.25 | $12.4M | -- | $0.00 | 0% | 5.44x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
AVNS
Avanos Medical, Inc.
|
14.67% | 0.742 | 24.92% | 1.26x |
|
IVF
INVO Fertility, Inc.
|
41.99% | 0.410 | 10.12% | 0.07x |
|
NMTC
NeuroOne Medical Technologies Corp.
|
3.64% | 3.209 | 0.6% | 3.40x |
|
NTRB
Nutriband, Inc.
|
3.31% | 3.036 | 0.32% | 7.07x |
|
NVNO
enVVeno Medical Corp.
|
2.62% | 2.708 | 4.32% | 12.90x |
|
SINT
SINTX Technologies, Inc.
|
45.47% | 0.781 | 22.94% | 1.47x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
AVNS
Avanos Medical, Inc.
|
$81.1M | $13.1M | -44.75% | -52.63% | 7.37% | $7M |
|
IVF
INVO Fertility, Inc.
|
$492.6K | -$1.6M | -188.23% | -471.28% | -93.08% | -$1.8M |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$1.5M | -$1.4M | -83.42% | -89.54% | -50.02% | -$1.5M |
|
NTRB
Nutriband, Inc.
|
$63K | -$3.9M | -159.71% | -164.64% | -1121.15% | -$1.8M |
|
NVNO
enVVeno Medical Corp.
|
-$120K | -$4.9M | -56.26% | -57.7% | -- | -$4.4M |
|
SINT
SINTX Technologies, Inc.
|
-$66K | -$3.4M | -115.95% | -208.36% | -1612.98% | -$2.6M |
Avanos Medical, Inc. vs. Competitors
-
Which has Higher Returns AVNS or IVF?
INVO Fertility, Inc. has a net margin of -0.79% compared to Avanos Medical, Inc.'s net margin of -150.51%. Avanos Medical, Inc.'s return on equity of -52.63% beat INVO Fertility, Inc.'s return on equity of -471.28%.
Company Gross Margin Earnings Per Share Invested Capital AVNSAvanos Medical, Inc.45.61% -$0.03 $911.7M IVFINVO Fertility, Inc.28.04% -$6.14 $10.1M -
What do Analysts Say About AVNS or IVF?
Avanos Medical, Inc. has a consensus price target of $14.00, signalling upside risk potential of 5.11%. On the other hand INVO Fertility, Inc. has an analysts' consensus of -- which suggests that it could grow by 10410.95%. Given that INVO Fertility, Inc. has higher upside potential than Avanos Medical, Inc., analysts believe INVO Fertility, Inc. is more attractive than Avanos Medical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AVNSAvanos Medical, Inc.0 1 0 IVFINVO Fertility, Inc.0 0 0 -
Is AVNS or IVF More Risky?
Avanos Medical, Inc. has a beta of 1.079, which suggesting that the stock is 7.932% more volatile than S&P 500. In comparison INVO Fertility, Inc. has a beta of 2.606, suggesting its more volatile than the S&P 500 by 160.551%.
-
Which is a Better Dividend Stock AVNS or IVF?
Avanos Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. INVO Fertility, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avanos Medical, Inc. pays -- of its earnings as a dividend. INVO Fertility, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AVNS or IVF?
Avanos Medical, Inc. quarterly revenues are $177.8M, which are larger than INVO Fertility, Inc. quarterly revenues of $1.8M. Avanos Medical, Inc.'s net income of -$1.4M is higher than INVO Fertility, Inc.'s net income of -$2.6M. Notably, Avanos Medical, Inc.'s price-to-earnings ratio is 45.94x while INVO Fertility, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avanos Medical, Inc. is 0.88x versus 0.03x for INVO Fertility, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVNSAvanos Medical, Inc.0.88x 45.94x $177.8M -$1.4M IVFINVO Fertility, Inc.0.03x -- $1.8M -$2.6M
-
Which has Higher Returns AVNS or NMTC?
NeuroOne Medical Technologies Corp. has a net margin of -0.79% compared to Avanos Medical, Inc.'s net margin of -59.08%. Avanos Medical, Inc.'s return on equity of -52.63% beat NeuroOne Medical Technologies Corp.'s return on equity of -89.54%.
Company Gross Margin Earnings Per Share Invested Capital AVNSAvanos Medical, Inc.45.61% -$0.03 $911.7M NMTCNeuroOne Medical Technologies Corp.55.77% -$0.03 $7.3M -
What do Analysts Say About AVNS or NMTC?
Avanos Medical, Inc. has a consensus price target of $14.00, signalling upside risk potential of 5.11%. On the other hand NeuroOne Medical Technologies Corp. has an analysts' consensus of $2.30 which suggests that it could grow by 159.89%. Given that NeuroOne Medical Technologies Corp. has higher upside potential than Avanos Medical, Inc., analysts believe NeuroOne Medical Technologies Corp. is more attractive than Avanos Medical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AVNSAvanos Medical, Inc.0 1 0 NMTCNeuroOne Medical Technologies Corp.1 0 0 -
Is AVNS or NMTC More Risky?
Avanos Medical, Inc. has a beta of 1.079, which suggesting that the stock is 7.932% more volatile than S&P 500. In comparison NeuroOne Medical Technologies Corp. has a beta of 0.575, suggesting its less volatile than the S&P 500 by 42.534%.
-
Which is a Better Dividend Stock AVNS or NMTC?
Avanos Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroOne Medical Technologies Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avanos Medical, Inc. pays -- of its earnings as a dividend. NeuroOne Medical Technologies Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AVNS or NMTC?
Avanos Medical, Inc. quarterly revenues are $177.8M, which are larger than NeuroOne Medical Technologies Corp. quarterly revenues of $2.7M. Avanos Medical, Inc.'s net income of -$1.4M is higher than NeuroOne Medical Technologies Corp.'s net income of -$1.6M. Notably, Avanos Medical, Inc.'s price-to-earnings ratio is 45.94x while NeuroOne Medical Technologies Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avanos Medical, Inc. is 0.88x versus 2.94x for NeuroOne Medical Technologies Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVNSAvanos Medical, Inc.0.88x 45.94x $177.8M -$1.4M NMTCNeuroOne Medical Technologies Corp.2.94x -- $2.7M -$1.6M
-
Which has Higher Returns AVNS or NTRB?
Nutriband, Inc. has a net margin of -0.79% compared to Avanos Medical, Inc.'s net margin of -1118.87%. Avanos Medical, Inc.'s return on equity of -52.63% beat Nutriband, Inc.'s return on equity of -164.64%.
Company Gross Margin Earnings Per Share Invested Capital AVNSAvanos Medical, Inc.45.61% -$0.03 $911.7M NTRBNutriband, Inc.18.2% -$0.32 $7.8M -
What do Analysts Say About AVNS or NTRB?
Avanos Medical, Inc. has a consensus price target of $14.00, signalling upside risk potential of 5.11%. On the other hand Nutriband, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 213.15%. Given that Nutriband, Inc. has higher upside potential than Avanos Medical, Inc., analysts believe Nutriband, Inc. is more attractive than Avanos Medical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AVNSAvanos Medical, Inc.0 1 0 NTRBNutriband, Inc.1 0 0 -
Is AVNS or NTRB More Risky?
Avanos Medical, Inc. has a beta of 1.079, which suggesting that the stock is 7.932% more volatile than S&P 500. In comparison Nutriband, Inc. has a beta of 1.840, suggesting its more volatile than the S&P 500 by 84.015%.
-
Which is a Better Dividend Stock AVNS or NTRB?
Avanos Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avanos Medical, Inc. pays -- of its earnings as a dividend. Nutriband, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AVNS or NTRB?
Avanos Medical, Inc. quarterly revenues are $177.8M, which are larger than Nutriband, Inc. quarterly revenues of $346.1K. Avanos Medical, Inc.'s net income of -$1.4M is higher than Nutriband, Inc.'s net income of -$3.9M. Notably, Avanos Medical, Inc.'s price-to-earnings ratio is 45.94x while Nutriband, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avanos Medical, Inc. is 0.88x versus 23.90x for Nutriband, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVNSAvanos Medical, Inc.0.88x 45.94x $177.8M -$1.4M NTRBNutriband, Inc.23.90x -- $346.1K -$3.9M
-
Which has Higher Returns AVNS or NVNO?
enVVeno Medical Corp. has a net margin of -0.79% compared to Avanos Medical, Inc.'s net margin of --. Avanos Medical, Inc.'s return on equity of -52.63% beat enVVeno Medical Corp.'s return on equity of -57.7%.
Company Gross Margin Earnings Per Share Invested Capital AVNSAvanos Medical, Inc.45.61% -$0.03 $911.7M NVNOenVVeno Medical Corp.-- -$0.23 $30.2M -
What do Analysts Say About AVNS or NVNO?
Avanos Medical, Inc. has a consensus price target of $14.00, signalling upside risk potential of 5.11%. On the other hand enVVeno Medical Corp. has an analysts' consensus of $12.50 which suggests that it could grow by 3567.23%. Given that enVVeno Medical Corp. has higher upside potential than Avanos Medical, Inc., analysts believe enVVeno Medical Corp. is more attractive than Avanos Medical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AVNSAvanos Medical, Inc.0 1 0 NVNOenVVeno Medical Corp.0 1 0 -
Is AVNS or NVNO More Risky?
Avanos Medical, Inc. has a beta of 1.079, which suggesting that the stock is 7.932% more volatile than S&P 500. In comparison enVVeno Medical Corp. has a beta of 1.040, suggesting its more volatile than the S&P 500 by 4.044%.
-
Which is a Better Dividend Stock AVNS or NVNO?
Avanos Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. enVVeno Medical Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avanos Medical, Inc. pays -- of its earnings as a dividend. enVVeno Medical Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AVNS or NVNO?
Avanos Medical, Inc. quarterly revenues are $177.8M, which are larger than enVVeno Medical Corp. quarterly revenues of --. Avanos Medical, Inc.'s net income of -$1.4M is higher than enVVeno Medical Corp.'s net income of -$4.5M. Notably, Avanos Medical, Inc.'s price-to-earnings ratio is 45.94x while enVVeno Medical Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avanos Medical, Inc. is 0.88x versus 473.07x for enVVeno Medical Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVNSAvanos Medical, Inc.0.88x 45.94x $177.8M -$1.4M NVNOenVVeno Medical Corp.473.07x -- -- -$4.5M
-
Which has Higher Returns AVNS or SINT?
SINTX Technologies, Inc. has a net margin of -0.79% compared to Avanos Medical, Inc.'s net margin of -1701.44%. Avanos Medical, Inc.'s return on equity of -52.63% beat SINTX Technologies, Inc.'s return on equity of -208.36%.
Company Gross Margin Earnings Per Share Invested Capital AVNSAvanos Medical, Inc.45.61% -$0.03 $911.7M SINTSINTX Technologies, Inc.-31.73% -$3.46 $7.5M -
What do Analysts Say About AVNS or SINT?
Avanos Medical, Inc. has a consensus price target of $14.00, signalling upside risk potential of 5.11%. On the other hand SINTX Technologies, Inc. has an analysts' consensus of $12.25 which suggests that it could grow by 281.62%. Given that SINTX Technologies, Inc. has higher upside potential than Avanos Medical, Inc., analysts believe SINTX Technologies, Inc. is more attractive than Avanos Medical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AVNSAvanos Medical, Inc.0 1 0 SINTSINTX Technologies, Inc.2 0 0 -
Is AVNS or SINT More Risky?
Avanos Medical, Inc. has a beta of 1.079, which suggesting that the stock is 7.932% more volatile than S&P 500. In comparison SINTX Technologies, Inc. has a beta of 0.649, suggesting its less volatile than the S&P 500 by 35.053%.
-
Which is a Better Dividend Stock AVNS or SINT?
Avanos Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SINTX Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avanos Medical, Inc. pays -- of its earnings as a dividend. SINTX Technologies, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AVNS or SINT?
Avanos Medical, Inc. quarterly revenues are $177.8M, which are larger than SINTX Technologies, Inc. quarterly revenues of $208K. Avanos Medical, Inc.'s net income of -$1.4M is higher than SINTX Technologies, Inc.'s net income of -$3.5M. Notably, Avanos Medical, Inc.'s price-to-earnings ratio is 45.94x while SINTX Technologies, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avanos Medical, Inc. is 0.88x versus 5.44x for SINTX Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVNSAvanos Medical, Inc.0.88x 45.94x $177.8M -$1.4M SINTSINTX Technologies, Inc.5.44x -- $208K -$3.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Sell
50
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Alerts
Sell
40
GDXU alert for Jan 31
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 38.85% over the past day.
Sell
34
PFSI alert for Jan 31
PennyMac Financial Services, Inc. [PFSI] is down 33.21% over the past day.
Sell
40
SHNY alert for Jan 31
MicroSectors Gold 3X Leveraged ETN [SHNY] is down 31.56% over the past day.
